One of the panels at Swiss Nordic bio: Anna Gran, New Ventures Lead. Nordics, Johnson & Johnson, Eric de La Fortelle, Venture Partner, Seventure Partners, Nina Rawal, Head of Life Science, lndustrifonden, Solange Romagnoli, Senior Director Global Business Development; Biomarker Programs. F. Hoffmann-La Roche Ltd, Andreas Jurgeit, Investment Director, Life Sciences, Merck Venture, Magnus Björsne, CEO, AstraZeneca BioVentureHub.
The Swiss Nordic Bio at the SIX Swiss Exchange, is a high-level partnering and investor event where Swiss and Nordic biotech startups, pharmaceutical companies and investors meet.
We are here to meet with new investors and companies to invite and partner up for 37 ºC Life Science Technology Conference & Exhibition, 6th – 7th June 2017, Stavanger Forum, Norway.